Virus-Like Particles Carrying HIV-1 Env with a Modulated Glycan Composition

被引:0
作者
Kaevitser, G. A. [1 ]
Samokhvalov, E. I. [1 ]
Scheblyakov, D. V. [1 ]
Gintsburg, A. L. [1 ,2 ]
Vzorov, A. N. [1 ,3 ]
机构
[1] Gamaleya Fed Res Ctr Epidemiol & Microbiol, Moscow 123098, Russia
[2] Minist Hlth Russian Federat, Sechenov First Moscow State Med Univ, Moscow 123098, Russia
[3] Moscow MV Lomonosov State Univ, Fac Biol, Dept Immunol, Moscow 119234, Russia
关键词
HIV-1; Env; glycoprotein; glycans; VLP; recombinant vaccinia virus; CHO cells; N-LINKED GLYCOSYLATION; NEUTRALIZATION SENSITIVITY; ENVELOPE GLYCOPROTEIN; CYTOPLASMIC DOMAIN; CD4; INDEPENDENCE; FULL-LENGTH; V3; LOOP; GP120; RECEPTOR; IMMUNOGENICITY;
D O I
10.1134/S0026893324700341
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously obtained highly immunogenic Env-VLPs ensure overcoming the natural resistance of HIV-1 surface proteins associated with their low level of incorporation and inaccessibility of conserved epitopes to induce neutralizing antibodies. We also adopted this technology to modify Env trimers of the ZM53(T/F) strain to produce Env-VLPs by recombinant vaccinia viruses (rVVs). For VLP production, rVVs expressing Env, Gag-Pol (HIV-1/SIV), and the cowpox virus hr gene, which overcomes the restriction of vaccinia virus replication in CHO cells, were used. The CHO Lec1 engineered cell line lacking GlcNAc-TI was used for generating VLPs with Env proteins containing a cytoplasmic (CT) domain affecting the surface subunit (SU) conformation. This has created the opportunity to modulate the glycan composition, and refine the conditions for their production, and optimize approaches to overcoming HIV-1 resistance associated with abundant glycosylation.
引用
收藏
页码:763 / 772
页数:10
相关论文
共 41 条
[1]   AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION [J].
BACK, NKT ;
SMIT, L ;
DEJONG, JJ ;
KEULEN, W ;
SCHUTTEN, M ;
GOUDSMIT, J ;
TERSMETTE, M .
VIROLOGY, 1994, 199 (02) :431-438
[2]   Role of Complex Carbohydrates in Human Immunodeficiency Virus Type 1 Infection and Resistance to Antibody Neutralization [J].
Binley, James M. ;
Ban, Yih-En Andrew ;
Crooks, Emma T. ;
Eggink, Dirk ;
Osawa, Keiko ;
Schief, William R. ;
Sanders, Rogier W. .
JOURNAL OF VIROLOGY, 2010, 84 (11) :5637-5655
[3]   SELECTION OF RECOMBINANT VACCINIA VIRUSES ON THE BASIS OF PLAQUE-FORMATION [J].
BLASCO, R ;
MOSS, B .
GENE, 1995, 158 (02) :157-162
[4]   Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer [J].
Cao, Liwei ;
Pauthner, Matthias ;
Andrabi, Raiees ;
Rantalainen, Kimmo ;
Berndsen, Zachary ;
Diedrich, Jolene K. ;
Menis, Sergey ;
Sok, Devin ;
Bastidas, Raiza ;
Park, Sung-Kyu Robin ;
Delahunty, Claire M. ;
He, Lin ;
Guenaga, Javier ;
Wyatt, Richard T. ;
Schief, William R. ;
Ward, Andrew B. ;
Yates, John R., III ;
Burton, Dennis R. ;
Paulson, James C. .
NATURE COMMUNICATIONS, 2018, 9
[5]   The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts [J].
Center, RJ ;
Earl, PL ;
Lebowitz, J ;
Schuck, P ;
Moss, B .
JOURNAL OF VIROLOGY, 2000, 74 (10) :4448-4455
[6]   HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation [J].
Checkley, Mary Ann ;
Luttge, Benjamin G. ;
Freed, Eric O. .
JOURNAL OF MOLECULAR BIOLOGY, 2011, 410 (04) :582-608
[7]   Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3 [J].
Cole, KS ;
Steckbeck, JD ;
Rowles, JL ;
Desrosiers, RC ;
Montelaro, RC .
JOURNAL OF VIROLOGY, 2004, 78 (03) :1525-1539
[8]   Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission [J].
Derdeyn, CA ;
Decker, JM ;
Bibollet-Ruche, F ;
Mokili, JL ;
Muldoon, M ;
Denham, SA ;
Heil, ML ;
Kasolo, F ;
Musonda, R ;
Hahn, BH ;
Shaw, GM ;
Korber, BT ;
Allen, S ;
Hunter, E .
SCIENCE, 2004, 303 (5666) :2019-2022
[9]   Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein [J].
Edwards, TG ;
Hoffman, TL ;
Baribaud, F ;
Wyss, S ;
LaBranche, CC ;
Romano, J ;
Adkinson, J ;
Sharron, M ;
Hoxie, JA ;
Doms, RW .
JOURNAL OF VIROLOGY, 2001, 75 (11) :5230-5239
[10]   Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies [J].
Haynes, Barton F. ;
Wiehe, Kevin ;
Borrrow, Persephone ;
Saunders, Kevin O. ;
Korber, Bette ;
Wagh, Kshitij ;
McMichael, Andrew J. ;
Kelsoe, Garnett ;
Hahn, Beatrice H. ;
Alt, Frederick ;
Shaw, George M. .
NATURE REVIEWS IMMUNOLOGY, 2023, 23 (03) :142-158